• Author: Shari S. Rogal
Clear all

Rates and factors associated with hepatocellular carcinoma diagnosis, stage, treatment, and survival

Abstract: BACKGROUND AND AIMS: Up-to-date information is needed on hepatocellular carcinoma (HCC) diagnosis, stage, treatment, and survival. METHODS: Of > 2000 patients with a new …

Practice changing RCT design and rationale: Abbreviated MRI plus AFP vs. ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study)

Abstract: Abdominal ultrasound every 6 months with or without serum alpha-fetoprotein (AFP) is recommended for hepatocellular carcinoma (HCC) screening in patients with cirrhosis. …

Increasing goals of care discussions among Veterans with cirrhosis: A Veterans Health Administration quality improvement initiative

Abstract: INTRODUCTION: Goals of care discussions (GCDs) are recommended for patients with cirrhosis but rarely conducted. Since 2017, the Veterans Health Administration has …

Comparing the effectiveness of implementation strategies to improve liver and colon cancer screening for Veterans: Protocol for a large cluster-randomized implementation study

Abstract: BACKGROUND: Screening for gastrointestinal (GI) cancers, specifically colorectal cancer (CRC) and hepatocellular carcinoma (HCC), is often inadequately and inequitably …

Screening high-risk Veterans for cirrhosis: Taking a stepwise population health approach

Abstract: Background: Because cirrhosis is often unrecognized, we aimed to develop a stepwise screening algorithm for cirrhosis in the Veterans Health Administration (VHA) and …

Identifying and treating metabolic dysfunction-associated steatotic liver disease among at-risk Veterans

Abstract: INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD), an increasing public health concern, remains challenging to diagnose and risk-stratify. We …

Early paracentesis is associated with better prognosis compared with late or no-paracentesis in hospitalized veterans with cirrhosis and ascites

Abstract: Guidelines recommend that all hospitalized patients with cirrhosis and ascites receive an early (<24 h from admission) paracentesis. However, national data are not …